Skip to content

Dynaloc for Treatment of Femoral Neck Fractures

Dynaloc vs. Multiple Cancellous Screws for Treatment of Femoral Neck Fractures

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02030431
Enrollment
150
Registered
2014-01-08
Start date
2014-03-31
Completion date
2015-10-31
Last updated
2015-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Femoral Neck Fracture

Brief summary

A prospective, randomized study comparing the effectiveness of a new system, Dynaloc compared with three cancellous screws, for osteosynthesis of femoral neck fractures

Interventions

DEVICEDynaloc

Sponsors

Aarhus University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to 110 Years
Healthy volunteers
No

Inclusion criteria

* Adult men or women (see age specifications below) with subcapital femoral neck fractures (stable or unstable) confirmed with anteroposterior and lateral hip radiographs, computed tomography, or magnetic resonance imaging (MRI). * Patients between 50 and 69 years of age with any Garden type femoral neck fracture * Patients older than 70 years of age with femoral neck fractures Garden type I and II * Patients older than 70 years of age with a femoral neck fracture Garden types III and IV and contraindication to hemiarthroplasty. * Operative treatment within 4 days (i.e., 72 hours) of presenting to the emergency room. * Patient was ambulatory prior to fracture, though they may have used an aid such as a cane or a walker. * Anticipated medical optimalization of the patient for operative fixation of the hip. * Provision of informed consent by patient or proxy. * Low energy fracture (defined as a fall from standing height). * No other major trauma.

Exclusion criteria

* Associated major injuries of the lower extremity (i.e., ipsilateral or contralateral fractures of the foot, ankle, tibia, fibula, knee, or femur; dislocations of the ankle, knee, or hip; or femoral head defects or fracture). * Retained hardware around the affected hip. * Abnormal opposite hip making end-point evaluation impossible * Infection around the hip (i.e., soft tissue or bone). * Patients with disorders of bone metabolism other than osteoporosis (i.e., Paget's disease, renal osteodystrophy). * Moderate or severe cognitively impaired patients (i.e., Six Item Screener with three or more errors). * Patients with Parkinson's disease (or dementia or other neurological deficit) severe enough to increase the likelihood of falling or severe enough to compromise rehabilitation. * Likely problems, in the judgment of the investigators, with maintaining follow-up. We will, for example, exclude patients with no fixed address, those who report a plan to move out of town in the next year, or intellectually challenged patients without adequate family support.

Design outcomes

Primary

MeasureTime frame
Shortening of the femoral neck1 year

Secondary

MeasureTime frame
Reoperation1 year

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026